What is EvolutionaryScale?
EvolutionaryScale is dedicated to advancing artificial intelligence for biological comprehension, aiming to enhance human health and societal well-being through open, safe, and responsible research. The company's core mission involves partnering with the scientific community to develop frontier models for biology, positioning AI to enable the programmability of molecules and entire cells. This transformative approach is set to redefine biological design over the next decade.
How much funding has EvolutionaryScale raised?
EvolutionaryScale has raised a total of $142M across 1 funding round:
Angel/Seed
$142M
Angel/Seed (2024): $142M with participation from Lux Capital
Key Investors in EvolutionaryScale
Lux Capital
Lux Capital is a New York-based venture capital firm that invests in early-stage and growth-stage companies at the intersection of science and technology, backing founders in frontier areas such as AI, robotics, space, defense, biotechnology, and advanced materials from seed through IPO or acquisition.
What's next for EvolutionaryScale?
The substantial enterprise-level backing positions EvolutionaryScale for accelerated growth and innovation. This capital infusion is expected to fuel the development of more sophisticated AI models for biological design, potentially leading to breakthroughs in drug discovery, synthetic biology, and personalized medicine. The company's strategic focus on responsible AI research suggests a commitment to ethical development as it scales its operations and expands its scientific partnerships.
See full EvolutionaryScale company page
